Suppr超能文献

特非那定(一种非镇静性抗组胺药)的临床研究。

Clinical investigation of terfenadine, a non-sedating antihistamine.

作者信息

Brandon M L, Weiner M

出版信息

Ann Allergy. 1980 Feb;44(2):71-5.

PMID:6102442
Abstract

Terfenadine was evaluated for the relief of symptoms in patients with allergic pollinosis on a double-blind basis. Terfenadine 20 mg tid was as effective as Chlorpheniramine maleate 4 mg tid. Chlorpheniramine consistently showed a higher incidence of sedation than placebo. None of the terfenadein dosage schedules up to 200 mg tid caused sedation significantly different from that of placebo. Terfenadine appears to be the first antihistamine to lack significant central nervous system effects.

摘要

特非那定在双盲试验基础上对过敏性花粉症患者的症状缓解情况进行了评估。特非那定20毫克每日三次与马来酸氯苯那敏4毫克每日三次效果相当。氯苯那敏的镇静发生率始终高于安慰剂。高达200毫克每日三次的特非那定剂量方案均未导致与安慰剂有显著差异的镇静作用。特非那定似乎是首个无明显中枢神经系统作用的抗组胺药。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验